ADPT
Adaptive Biotechnologies Corporation
Halal Rating :
See Details
Last Price
$3.01
Last updated:
Market Cap
$396.42m
7D Change
15.77%
1 Year Change
-53.19%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Feb. 14, 2024
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2023 | $42.77m | $188.3m | $4.61m | $3.01m | 10.79% | 1.60% |
| Sept. 30, 2023 | $34.27m | $133.52m | $4.28m | $3.65m | 12.50% | 2.74% |
| June 30, 2023 | $45.32m | $146.95m | $3.61m | $3.6m | 7.97% | 2.45% |
Company Impact
Help us evaluate Adaptive Biotechnologies Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.